Sanofi is shown in a comparative P/E ratio table but is not discussed by the creator.
Source Post
The creator discusses her recent purchase of Novo Nordisk stock, highlighting its strong financial performa...
Alice CeeNew
The creator discusses her recent purchase of Novo Nordisk stock, highlighting its strong financial performance, patent protection for Ozempic, and its role as a defensive investment compared to volatile AI stocks.
Linked Mentions
Tickers discussed in this post
Eli Lilly is shown in a comparative P/E ratio table but is not discussed by the creator.
Pfizer is shown in a comparative P/E ratio table but is not discussed by the creator.
The creator explicitly states she bought $2,400 of Novo Nordisk stock and presents a bullish thesis based on financials and defensive positioning.
Linked Signals
Tracked calls opened from this post
NVObuy opened Jun 30, 2026
-2.23%